Guardian Pharmacy Services (GRDN) Cash from Financing Activities (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Cash from Financing Activities data on file, last reported at -$2.0 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 23.56% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.4 million (up 68.84% YoY) and the FY2025 annual result came in at -$7.1 million, up 70.1% from the prior year.
• Cash from Financing Activities fell to -$2.0 million in Q1 2026 per GRDN's latest filing, from -$758000.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $44.9 million in Q3 2024, with the low at -$48.3 million in Q4 2024.
• Average Cash from Financing Activities over 4 years is -$4.6 million, with a median of -$2.4 million recorded in 2025.
• Year-over-year, Cash from Financing Activities sank 263.62% in 2024 and surged 98.43% in 2025.
• Guardian Pharmacy Services' Cash from Financing Activities stood at -$13.3 million in 2023, then slumped by 263.62% to -$48.3 million in 2024, then surged by 98.43% to -$758000.0 in 2025, then tumbled by 168.87% to -$2.0 million in 2026.
• Business Quant data shows GRDN's Cash from Financing Activities at -$2.0 million in Q1 2026, -$758000.0 in Q4 2025, and -$1.5 million in Q3 2025.